Strategic acquisitions Jorgensen Laboratories has recently invested in assets from Vetlabs, signaling a strategy to expand its product portfolio and distribution capabilities, presenting an opportunity to cross-sell additional veterinary equipment and supplies to an enlarged customer base.

Expanded distribution reach With over 40 international distributors and collaboration with major U.S. distributors, there is potential to introduce new product lines, exclusive formulations, or bundled offers to existing distributor networks to drive incremental revenue.

Wound care partnerships A past exclusive distribution agreement for Imbed Biosciences MicroLyte VET wound dressings indicates demand for advanced wound care solutions; explore new wound care products or access to veterinary clinics seeking innovative dressings and therapies.

Mid-sized growth profile Revenue in the low-to-mid single-digit millions and employee scale around a few dozen to a couple hundred suggest a mid-market enterprise that may be receptive to scalable, cost-effective equipment upgrades, service contracts, or tiered reseller programs.

Tech and security readiness Adoption of multiple tech tools (WordPress, trackJS, HIPAA compliance, security plugins) demonstrates an emphasis on digital presence and data protection, indicating suitability for selling compliant software-enabled devices, telemetry, or service platforms that integrate with clinic workflows.